[b]NSAV gearing up for major Feb. run[/b]
[IMG]http://i1263.photobucket.com/albums/ii625/subflyer8/NSAVConversion_zpsc562187a.png[/IMG]
[url]http://i1263.photobucket.com/albums/ii625/subflyer8/NSAVConversion_zpsc562187a.png[/url] Chart Direct Link
[b]NSAV DD[/b]
Share Structure:
Market Value1 $248,720 a/o Jan 25, 2013
Shares Outstanding 621,801,136 a/o Jan 23, 2013
Float 500,721,621 a/o Jan 23, 2013
Authorized Shares 1,000,000,000 a/o Jan 23, 2013
Par Value 0.001
[url]http://www.otcmarkets.com/stock/NSAV/company-info[/url] OTC markets Direct Link
[b]4 Day Historical Volume![/b]
Jan 22, 2012 Volume: 4,710,940
Jan 23, 2012 Volume: 13,864,667
Jan 24, 2012 Volume: 58,861,564 (VERT was taken out Jan 24, 2012)
Jan 25, 2012 Volume: 61,966,220 (VNDM was taken out Jan 25, 2012)
[b]Volume is increasing! Conversions are now at an end!![/b]
Hystorical September 26, 2012 E-mail Correspondence between CEO of NSAV David Saltrelli and another Investor!
CEO ANSWERS E-MAIL:
Question: What are the goals for this company moving forward? I don't see any definitive goals set for the company on the website, reaching millions of buyers is not exactly an affirmative answer for stock holders when looking to invest in the stock.
ANSWER: NSAV sells Savings Certificates. Our goal is to sell millions of them.
Go to our website and click on the 4 sections and follow the links and you will see how we make the respective sales.
We expect to be profitable in October and then we expect to double profits every month for the next 6 - 10 months. The 6 month profit goal is $1,000,000 per month from selling Savings Certificates.
Question: was just concerned I have not heard or seen any follow ups. Is FamilyCoOp going to run ads? Also, who is selling the sales certificates if you don't mind me asking? And by profitable in October do you mean the 3rd quarter results that are due out will reveal a strong quarter?
ANSWER NSL sells through Affiliate Partners and also direct.
Family Savings CoOp advertises their program
Our quarter ended 8/31/12 and the Q should be out around 10/15/12
October is in this current quarter which will end November 30th.
Question: what is going on with the stock, Can you help the stock by saying something?
Answer: Nothing we can do at the current time. Asher and Southridge are converting their loans into stock and selling the stock in the market.
Nothing I can say to help at this time.
We are selling everyday and we anticipate being profitable in October. That is what we are concentrating all our efforts on.
Question: Does Asher and Southridge converting their loans into stock and selling the stock in the market help the stock down the road I would hope?
Answer:
By converting loans into stock it pays off the loans and the company becomes debt free. Then with profits and no debt the stock should go up, but nothing is guaranteed. All the best,
David Saltrelli, President
Net Savings Link, Inc. | Stock Symbol: NSAV
(727) 442 2600 (Office) | (727) 482 5800 (Cell)
www.NetSavingsLink.com | LinkedIn
Fundraising | Incentives | Joint Ventures | Business Opportunities
E-Mail Correspondence between CEO of NSAV David Saltrellli and myself!
On Jan 25, 2013, at 3:38 PM, David Saltrelli <david@netsavingslink.com> wrote:
> Alex,
>
> Our 10K, year end report, is due February 28th. All info on conversions and sales will be in there as well are information on what has occurred during the last 60 days. Sorry, but you will have to wait for that report. We may put out news sooner via a press release. We cannot give information out to individual shareholders.
>
>
> All the best,
>
>
>
> David Saltrelli, President
>
> Net Savings Link, Inc. | Stock Symbol: NSAV
>
> (727) 442 2600 (Office) | (727) 482 5800 (Cell)
>
> www.NetSavingsLink.com | LinkedIn
>
> Fundraising | Incentives | Joint Ventures | Business Opportunities
>
>
>
> On Fri, Jan 25, 2013 at 3:07 PM, Alex Woods- Leo <alexmwoodsleo@gmail.com> wrote:
>
> David
>
> My name is Alex Leo and i am a current shareholder and was wondering how many conversions are left. Seems theres still some shares to be sold. We took out VERT yesterday and we are stuck on VNDM right now. However many of us are wondering about how many more shares are to be dumped?
>
> If this can be answered this would be great. Also in an e-mail to a fellow investor back in September you had stated that NSAV should be putting out financials around Feb 28. is that still the case? If so does it still look like NSAV may be posting Debt Free status?
>
> Long and Strong
>
> Alex Leo
NSAV gearing up for major Feb. run
Top 10 Most Recent News Articles
CARsgen's CT1182 Data Opens a Careful New CAR-T Test
Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...
Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle
A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...
Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test
Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...
Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch
By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...
Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach
Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...
Continue Reading
Human Frontier Mission Puts AI Research on Display
A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...
Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint
A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...
Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look
Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...
Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos
A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...
Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims
Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...
Continue ReadingTop 5 Most Recently Viewed Articles
Neurotrope, Inc. Achieves New Milestone with Stock Surge
Neurotrope, Inc. Reaches New Stock Milestone Neurotrope, Inc. (NASDAQ: NTRP) has recently achieved a significant milestone in the stock market, soaring to a 52-week high with its price reaching $7.00. This impressive climb indicates a remarkable 124.95% increase over the past year, showcasing strong investor interest and confidence in the company's future prospects. The...
Continue Reading
Lil Nas X's Legal Challenges and Public Struggles Unfold
Lil Nas X Pleads Not Guilty to Serious Charges Grammy-winning musician Lil Nas X has recently made headlines for pleading not guilty to multiple felony charges stemming from an incident involving police officers. This situation arose when he was found walking unclothed on the streets of Los Angeles. Understanding the Legal Battle Ahead The rapper, known legally as Montero...
Continue Reading
Exyte's Strategic Acquisition of TTP Group Enhanced Operations
Exyte Acquires TTP Group to Strengthen Engineering Expertise Exyte, a leader in high-tech facility engineering, has officially completed the acquisition of TTP Group, enhancing its operations and expertise especially in the biopharma and life sciences sectors. This acquisition marks a significant milestone for Exyte as it melds TTP's capabilities with its own, aiming to...
Continue Reading
Unveiling Health Innovations: Zepp Health at CES 2024 Events
Zepp Health Showcases Innovative Technologies at CES Zepp Health Corporation (NYSE: ZEPP), a leader in health technology and smart wearables, is excited to announce its participation in significant media events like Pepcom and ShowStoppers at CES. These occasions will showcase Zepp Health's latest advancements in smart wearables and health technologies, aimed at...
Continue Reading
Meridian Locks $186M Loan for NJ Condo Project
New Jersey's Coastline Gets a $186 Million Facelift Here's a move that'll shake the Jersey Shore awake: Meridian Capital Group's just put their money where the sand is with a massive $186 million scoop for a new high-end condominium project in Asbury Park. You couldn't make up a better setting—a beachfront spot ripe for some high-end living. But let's not get too...
Continue Reading